Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma.

Tzogani K, Hennik PV, Walsh I, De Graeff P, Folin A, Sjöberg J, Salmonson T, Bergh J, Laane E, Ludwig H, Gisselbrecht C, Pignatti F.

Oncologist. 2018 Jul;23(7):870. doi: 10.1634/theoncologist.2017-0301erratum. No abstract available.

2.

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study.

Mohty M, Terpos E, Mateos MV, Cavo M, Lejniece S, Beksac M, Bekadja MA, Legiec W, Dimopoulos M, Stankovic S, Durán MS, De Stefano V, Corso A, Kochkareva Y, Laane E, Berthou C, Salwender H, Masliak Z, Pečeliūnas V, Willenbacher W, Silva J, Louw V, Nemet D, Borbényi Z, Abadi U, Pedersen RS, Černelč P, Potamianou A, Couturier C, Feys C, Thoret-Bauchet F, Boccadoro M; EMMOS Investigators.

Clin Lymphoma Myeloma Leuk. 2018 Oct;18(10):e401-e419. doi: 10.1016/j.clml.2018.06.018. Epub 2018 Jun 25.

3.

EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma.

Tzogani K, van Hennik P, Walsh I, De Graeff P, Folin A, Sjöberg J, Salmonson T, Bergh J, Laane E, Ludwig H, Gisselbrecht C, Pignatti F.

Oncologist. 2018 May;23(5):631-636. doi: 10.1634/theoncologist.2017-0301. Epub 2017 Nov 30. Erratum in: Oncologist. 2018 Jul;23(7):870.

4.

The European Medicines Agency Review of Carfilzomib for the Treatment of Adult Patients with Multiple Myeloma Who Have Received at Least One Prior Therapy.

Tzogani K, Camarero Jiménez J, Garcia I, Sancho-López A, Martin M, Moreau A, Demolis P, Salmonson T, Bergh J, Laane E, Ludwig H, Gisselbrecht C, Pignatti F.

Oncologist. 2017 Nov;22(11):1339-1346. doi: 10.1634/theoncologist.2017-0184. Epub 2017 Sep 21.

5.

Investigation and management of IgM and Waldenström-associated peripheral neuropathies: recommendations from the IWWM-8 consensus panel.

D'Sa S, Kersten MJ, Castillo JJ, Dimopoulos M, Kastritis E, Laane E, Leblond V, Merlini G, Treon SP, Vos JM, Lunn MP.

Br J Haematol. 2017 Mar;176(5):728-742. doi: 10.1111/bjh.14492. Epub 2017 Feb 15.

PMID:
28198999
6.

The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany.

Berntorp E, Dargaud Y, Hart D, Lobet S, Mancuso ME, d'Oiron R, Perry D, Pollard D, van den Berg M, Blatný J, Chambost H, Doria AS, Holme PA, Kaczmarek R, Mantovani L, McLaughlin P, Nanayakkara L, Petrini P, Sannié T, Laane E, Maia R, Dettoraki A, Farrell A, Halimeh S, Raza S, Taylor S.

Eur J Haematol. 2017 Jan;98 Suppl 85:1-15. doi: 10.1111/ejh.12828.

PMID:
28101938
7.

Acute de novo Leukemia in Estonia and Western Sweden 1982-2006: Positive Trend in the Survival of Acute Leukemia over 25 Years.

Hulegårdh E, Punab M, Holmberg E, Palk K, Laane E, Everaus H, Wennström L, Stockelberg D.

Acta Haematol. 2016;136(3):167-73. doi: 10.1159/000446525. Epub 2016 Aug 19.

PMID:
27537981
8.

The European Medicines Agency Review of Brentuximab Vedotin (Adcetris) for the Treatment of Adult Patients With Relapsed or Refractory CD30+ Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use.

Gravanis I, Tzogani K, van Hennik P, de Graeff P, Schmitt P, Mueller-Berghaus J, Salmonson T, Gisselbrecht C, Laane E, Bergmann L, Pignatti F.

Oncologist. 2016 Jan;21(1):102-9. doi: 10.1634/theoncologist.2015-0276. Epub 2015 Nov 30.

9.

The European medicines agency review of pomalidomide in combination with low-dose dexamethasone for the treatment of adult patients with multiple myeloma: summary of the scientific assessment of the committee for medicinal products for human use.

Hanaizi Z, Flores B, Hemmings R, Camarero J, Sancho-Lopez A, Salmonson T, Gisselbrecht C, Laane E, Pignatti F.

Oncologist. 2015 Mar;20(3):329-34. doi: 10.1634/theoncologist.2014-0073. Epub 2015 Feb 11. Review.

10.

Dendritic cells in bone marrow at diagnosis and after chemotherapy in adult patients with acute myeloid leukaemia.

Derolf AR, Laane E, Björklund E, Saft L, Björkholm M, Porwit A.

Scand J Immunol. 2014 Dec;80(6):424-31. doi: 10.1111/sji.12223.

11.

The European medicines agency review of bosutinib for the treatment of adult patients with chronic myelogenous leukemia: summary of the scientific assessment of the committee for medicinal products for human use.

Hanaizi Z, Unkrig C, Enzmann H, Camarero J, Sancho-Lopez A, Salmonson T, Gisselbrecht C, Laane E, Pignatti F.

Oncologist. 2014 Apr;19(4):421-5. doi: 10.1634/theoncologist.2013-0294. Epub 2014 Mar 25.

12.

Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial.

Mellqvist UH, Gimsing P, Hjertner O, Lenhoff S, Laane E, Remes K, Steingrimsdottir H, Abildgaard N, Ahlberg L, Blimark C, Dahl IM, Forsberg K, Gedde-Dahl T, Gregersen H, Gruber A, Guldbrandsen N, Haukås E, Carlson K, Kvam AK, Nahi H, Lindås R, Andersen NF, Turesson I, Waage A, Westin J; Nordic Myeloma Study Group.

Blood. 2013 Jun 6;121(23):4647-54. doi: 10.1182/blood-2012-11-464503. Epub 2013 Apr 24.

13.

The European Medicines Agency review of pixantrone for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin's B-cell lymphomas: summary of the scientific assessment of the committee for medicinal products for human use.

Péan E, Flores B, Hudson I, Sjöberg J, Dunder K, Salmonson T, Gisselbrecht C, Laane E, Pignatti F.

Oncologist. 2013;18(5):625-33. doi: 10.1634/theoncologist.2013-0020. Epub 2013 Apr 24.

14.

Sequential population-based studies over 25 years on the incidence and survival of acute de novo leukemias in Estonia and in a well-defined region of western Sweden during 1982-2006: a survey of patients aged ≥65 years.

Punab M, Palk K, Varik M, Laane E, Everaus H, Holmberg E, Hulegårdh E, Wennström L, Safai-Kutti S, Stockelberg D, Kutti J.

Med Oncol. 2013 Mar;30(1):487. doi: 10.1007/s12032-013-0487-x. Epub 2013 Feb 9.

PMID:
23397082
15.

Sorafenib has potent antitumor activity against multiple myeloma in vitro, ex vivo, and in vivo in the 5T33MM mouse model.

Kharaziha P, De Raeve H, Fristedt C, Li Q, Gruber A, Johnsson P, Kokaraki G, Panzar M, Laane E, Osterborg A, Zhivotovsky B, Jernberg-Wiklund H, Grandér D, Celsing F, Björkholm M, Vanderkerken K, Panaretakis T.

Cancer Res. 2012 Oct 15;72(20):5348-62. doi: 10.1158/0008-5472.CAN-12-0658. Epub 2012 Sep 4.

16.

Glucocorticoid-induced cell death is mediated through reduced glucose metabolism in lymphoid leukemia cells.

Buentke E, Nordström A, Lin H, Björklund AC, Laane E, Harada M, Lu L, Tegnebratt T, Stone-Elander S, Heyman M, Söderhäll S, Porwit A, Ostenson CG, Shoshan M, Tamm KP, Grandér D.

Blood Cancer J. 2011 Jul;1(7):e31. doi: 10.1038/bcj.2011.27. Epub 2011 Jul 29.

17.

Autophagy as the main means of cytotoxicity by glucocorticoids in hematological malignancies.

Grandér D, Kharaziha P, Laane E, Pokrovskaja K, Panaretakis T.

Autophagy. 2009 Nov;5(8):1198-200. Epub 2009 Nov 18.

PMID:
19855186
18.

Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy.

Laane E, Tamm KP, Buentke E, Ito K, Kharaziha P, Oscarsson J, Corcoran M, Björklund AC, Hultenby K, Lundin J, Heyman M, Söderhäll S, Mazur J, Porwit A, Pandolfi PP, Zhivotovsky B, Panaretakis T, Grandér D.

Cell Death Differ. 2009 Jul;16(7):1018-29. doi: 10.1038/cdd.2009.46. Epub 2009 Apr 24. Erratum in: Cell Death Differ. 2009 Jul;16(7):1071. Khahariza, P [corrected to Kharaziha, P].

19.

Dexamethasone-induced apoptosis in acute lymphoblastic leukemia involves differential regulation of Bcl-2 family members.

Laane E, Panaretakis T, Pokrovskaja K, Buentke E, Corcoran M, Söderhäll S, Heyman M, Mazur J, Zhivotovsky B, Porwit A, Grandér D.

Haematologica. 2007 Nov;92(11):1460-9.

20.

Dendritic cell regeneration in the bone marrow of children treated for acute lymphoblastic leukaemia.

Laane E, Björklund E, Mazur J, Lönnerholm G, Söderhäll S, Porwit A.

Scand J Immunol. 2007 Nov;66(5):572-83. Epub 2007 Sep 24.

21.
22.

Doxorubicin requires the sequential activation of caspase-2, protein kinase Cdelta, and c-Jun NH2-terminal kinase to induce apoptosis.

Panaretakis T, Laane E, Pokrovskaja K, Björklund AC, Moustakas A, Zhivotovsky B, Heyman M, Shoshan MC, Grandér D.

Mol Biol Cell. 2005 Aug;16(8):3821-31. Epub 2005 May 25.

23.

Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma.

Laane E, Tani E, Björklund E, Elmberger G, Everaus H, Skoog L, Porwit-MacDonald A.

Cytometry B Clin Cytom. 2005 Mar;64(1):34-42.

24.

[Effect of nifedipine in chronic left ventricular insufficiency in patients with post-infarction heart aneurysm].

Soopyl'd IuKh, Laane EIa, Uuskiula MM, Altraia EM.

Ter Arkh. 1986;58(5):93-5. Russian.

PMID:
3738800
25.
26.

[Gas exchange and hemodynamic changes resulting from the rehabilitative therapy of ischemic heart disease].

Laane EIa, Riĭv IaIa, Ruga VIu.

Klin Med (Mosk). 1982 May;60(5):72-4. Russian. No abstract available.

PMID:
6810016
27.

[Oxygen metabolic characteristics in ischemic heart disease].

Ruga VIu, Laane EIa.

Kardiologiia. 1981 Apr;21(4):110-1. Russian. No abstract available.

PMID:
7253386
28.

[Changes in erythrocytes and external respiration in alcoholism].

Viare KhIa, Laane EIa, Saarma IuM.

Zh Nevropatol Psikhiatr Im S S Korsakova. 1975;75(2):250-6. Russian. No abstract available.

PMID:
1119266
29.

[Use of an oxygen-air gas mixture enriched with carbon dioxide for treating disorders of the coronary circulation].

Laane EIa.

Ter Arkh. 1972 Dec;44(12):96-9. Russian. No abstract available.

PMID:
4666362
30.

[The effect of baths on obesity].

Laane E, Suĭia R.

Vopr Kurortol Fizioter Lech Fiz Kult. 1972 May-Jun;37(3):258-60. Russian. No abstract available.

PMID:
5048117
31.

[Electrophonocardiographic results in patients with hypertensive disease during changes in intra-thoracic pressure].

Laane EIa.

Kardiologiia. 1971 May;11(5):143-5. Russian. No abstract available.

PMID:
5126313
32.

[Effect of alcohol on the cardiovascular system in healthy persons].

Laane E.

Ter Arkh. 1971 May;43(5):63-6. Russian. No abstract available.

PMID:
5117934
33.

[Effect of steam baths on the cardiovascular system in patients with hypertension].

Laane E, Suiĭa R.

Sov Med. 1971 Apr;34(4):90-4. Russian. No abstract available.

PMID:
5143763
34.

[Results of oxyhemographic study at the time of Stange's test].

Laane EIa.

Ter Arkh. 1970 Mar;42(3):69-72. Russian. No abstract available.

PMID:
5453872
35.

[On the latent Hegglin syndrome].

Laane EIa.

Ter Arkh. 1967 May;39(5):94-7. Russian. No abstract available.

PMID:
5610185

Supplemental Content

Support Center